HIV is infamous for its ability to hide in the human body for decades, typically requiring long-term treatment to prevent a ...

Tislelizumab addition to CRT improved survival in ESCC, with group B showing a 1-year PFS rate of 73% and OS rate of 85%. The trial's primary endpoint was PFS, with secondary endpoints including OS, ...

I was taken care of by my dad when she wasn’t around, and while he treated me well, we didn’t connect the same way that I did ...

Novel regimen GO-4, combining melphalan, BCNU, hydroxocobalamin, ascorbic acid, and autologous stem cells shows manageable adverse reactions and a strong signal of efficacy in patients with BRCA-relat ...

New gene-editing project targets thalassemia’s root cause A new research project at the Cyprus Institute of Neurology and ...

Also known as a PDRN treatment, this skin-care technique may provide anti-aging, anti-inflammatory, and ...

From the 2010s to the present, the existing technologies in the clinic and operating room have been improved with the goals ...

The new luxury for the ultra-high-net-worth individual is not a product but time, driving a trillion-dollar global wellness ...

Touted by longevity experts, celebrated by biohackers, and whispered about in elite wellness circles, NAD+ is the molecule at ...

The children of Lance Shockley, Marcellus “Khaliifah” Williams Sr. and Kevin Johnson shed light on oft-forgotten experiences.

Michael Ritchie, chief commercial officer at Champions Oncology, explains what makes radiopharmaceuticals unique in the treatment of cancer.

A study published in Science reveals a cellular mechanism involved in the inheritance of genetic mutations. The study also ...